Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory CD19-positive B-ALL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Early research (Phase 1)UnknownNCT03559439
What this trial is testing

CD19-targeting CAR T Cells in Relapsed or Refractory CD19 Positive B-cell Malignancies

Who this might be right for
B-cell MalignancyB-cell LymphomaB-Cell Acute Lymphoblastic Leukaemia
Shanghai Tong Ren Hospital 9
Testing effectiveness (Phase 2)Looking for participantsNCT06179524
What this trial is testing

CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALL

Who this might be right for
Relapsed B-cell Acute Lymphoblastic LeukemiaRefractory B-cell Acute Lymphoblastic Leukemia
Beijing Yongtai Ruike Biotechnology Company Ltd 100
Early research (Phase 1)UnknownNCT04888442
What this trial is testing

Phase I Study of pCAR-19B in the Treatment of Adult CD19-positive Relapsed/Refractory B-ALL

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseRefractory Acute Lymphoblastic Leukemia
Chongqing Precision Biotech Co., Ltd 18
Early research (Phase 1)UnknownNCT05270772
What this trial is testing

CAR-T-19 Cells for Patients With CD19+ Relapse/Refractory B-ALL

Who this might be right for
CD19+ Relapse/Refractory B-ALL
Chinese PLA General Hospital 9
Very early researchLooking for participantsNCT07429461
What this trial is testing

Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia
Zhejiang University 16
Testing effectiveness (Phase 2)Study completedNCT03289455
What this trial is testing

CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
B Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRefractory Childhood Acute Lymphoblastic Leukemia+1 more
Autolus Limited 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT04404660
What this trial is testing

CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

Who this might be right for
Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia
Autolus Limited 153
Early research (Phase 1)Study completedNCT04888468
What this trial is testing

Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

Who this might be right for
Acute Lymphoblastic LeukemiaRelapsed Pediatric ALLRefractory Acute Lymphoblastic Leukemia
Chongqing Precision Biotech Co., Ltd 9
Early research (Phase 1)Looking for participantsNCT06173518
What this trial is testing

CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Who this might be right for
Relapsed or Refractory B Cell Acute Lymphoblastic LeukemiaRelapsed or Refractory B Cell Non-Hodgkin Lymphoma
Autolus Limited 30
Early research (Phase 1)Looking for participantsNCT05705570
What this trial is testing

Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia RefractoryB-cell Lymphoma Recurrent+3 more
Nelson Hamerschlak 30